FDA Approved: VYTORIN — Supplemental Application (Organon LLC)

View source ↗

Summary

The FDA approved a supplemental application for VYTORIN (ezetimibe and simvastatin) from Organon LLC to update the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Coronary Artery Disease
• Dyslipidemia
• Familial Hypercholesterolemia
• Hyperlipidemia

Drugs mentioned

• Vytorin (ezetimibe/simvastatin)

Snippet

SUPPL AP for VYTORIN (EZETIMIBE AND SIMVASTATIN)